-
- # #Tareas
	- DONE PREPARAR presentación de [[María Santamaría]]
	  SCHEDULED: <2024-04-04 Thu>
	- DONE [#A] PREPARAR presentación sobre las comunicaciones de [[STOP2030]] para la reunión con el Advisory Board
	  SCHEDULED: <2024-04-04 Thu>
	- DONE [#A] PREGUNTAR a [[Marina]] y [[Silvia]] si tienen claras algunas de las invitaciones que podríamos ir mandando ya para que [[yo]] vaya preparándolo
	  SCHEDULED: <2024-04-04 Thu>
	- DONE ENTERARME de si hay reunión con Sonia y [[Dolores]] y [[Adela]]
	  SCHEDULED: <2024-04-04 Thu>
	- TODO ACTUALIZAR lista de invitado al [[Evento]] con sugerencias de [[Marina]]
	  SCHEDULED: <2024-04-04 Thu>
	- TODO ESCRIBIR a [[Chema Buceta]] para preguntarle qué tal van las gestiones con [[Caixaforum]]
	  SCHEDULED: <2024-04-05 Fri>
	- TODO PEDIR Carteles para cribado de [[Chagas]] en el consulado el sábado [[2024/05/04]] a [[Scienseed]]
	  SCHEDULED: <2024-04-05 Fri>
	  DEADLINE: <2024-04-19 Fri>
	- TODO IR al cribado al consulado
	  SCHEDULED: <2024-05-04 Sat>
	-
	-
- # #Eventos
	- TODO 15:00 - 16:30: Reu equipo comunicaciones
	  SCHEDULED: <2024-04-04 Thu 15:00>
	  :AGENDA:
	  estimated: 1h
	  :END:
	- CANCELED 11:15 - 12:30: Presentación GEPI
	  SCHEDULED: <2024-04-04 Thu>
	- CANCELED 13:00 - 14:00: Reunión [[Ade]] + Sonia + [[Dolores]] + Borja
	  SCHEDULED: <2024-04-04 Thu 13:00>
	- TODO 16:00 - 17:00: [[STOP2030]] - STAB Meeting
	  SCHEDULED: <2024-04-04 Thu 16:00>
		- ## Notas
			- [[AK]]. To begin with ty to them. To be part of the STAB meeting and being availsable at the same time. I prepared a presentation which wont take more than 20-25 mins an get your input. We really value this. Adhoc afiliation with Liconsa. Affiliation to FMS. Estuvo en previous stop durante el ALIVE study.
			- John Amuasi: physician. Global health infectious diseases and global health department.
			- Raj Shankar Gosh: mefico trained in public health: working onf infectious Climate health and resistance and the founder at a startup in Dehli
			- Denise Mupfasoni: NTD department at WHO leading all the STH related activities. Key stakeholder on our. Geneva. Member as an observer in this group. Not a full member.
			- Pat Lamie: task force for global health. Colleague on AK durante unos 20 años.
			- Collins Okoyo: Kenya. Leader of WP3 on modelling and cost effectiveness.
			- Julie: Bridges, we lead wp5. Excited to hear.
			- Marina: Anthropologist. WP5 with bridges more focused on the comms.
			- Carla Valribiera: coordinating all the consortium members
			- AK: stop 1 y stop2 querían hacer un pivotal trial de la fdc y show safety and efficacy against STH
			- Liconsa responsability.
			- Liconsa tiene track record en gloabl health porque hacen el benznidazol y han prequalified ivermectin.
			- ISGlobal lidership de las biomedical sciences.
			- WP3 leaded by KEMRI: leaded by modelling and db but also as a siste.
			- wp4: the social sciences: acceptabiility feasibility and adherence: also clinical site, but also a leader through their expertise on other projects on acceptaibility.
			- WP5: policty, access, advocacy and communications.
			- Y por último Sanger working on developing surveillance methods por genomic ana
			- The target of the consorcios es crear goals and evidence needed by WHO in evaluating the incorporating this strategies  into programs.
			- We know that the FDC también es util para oncho, lf, scabies y demás pero tenemos que elegir una disease of particular interest to perform the particular studies. So far the achievements have been: submission to EMA through art 58. the main target is leading the way to prequalification to WHO. We did the pivotal trial that demonstrated safety efficacy against T. Trichiura.
			- Our current main challenges are safety and acceptability. We've had conversations with the department in Geneva to align our strategies.
			- Evaluation of implementation strategies, pathways to programs and an access plan.
			- We look for your expertise in these 3 aspects. Our interest is go beyond the science limited to STH and a vision of global health and a program of implementation.
			- TODO LEER 2030 targets for soil-transmitted helminthiases de WHO
			  SCHEDULED: <2024-04-21 Sun>
			- Of particular interest where the ocular nosequé
			- El clinical trial is under review. Nothing to highlight regarding safety, which lead us to go to test safety with bigger populations.
			- consideramos lo de 3 dosis para situaciones que no son las de MDA sino otros escenarios.
			- For strongi we didn't reach the recruitement size. The answer we wanted to provide we couldnt give.
			- Our project is proposing an innovation with our fdc but also for other ways of getting ivm.
			- Safety, palatability and
-
- ## Cosas de gastos del [[Evento]]
	- Sala, catering, técnicos (Caixaforum)
	- Sala NH, comida NH
	- Chema Buceta
		- Se encarga de la relación con Caixaforum
		- Se encarga de la visita a Liconsa/Chemo/nosecual
	- Comida CA
	- Scienseed
		- Buscar cuántas horas han metido al evento
		- Me dio autorización (informal) Marina a decirles que si necesitan facturar algo por fuera lo hagan